Fibroblast activation protein: A cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosis

Hepatology

Volumn 29, Issue 6, 1999, Pages 1768-1778

  Levy, M T ^a   McCaughan, G W ^a   Abbott, C A ^a   Park, J E ^a   Cunningham, A M ^a   Muller, E ^a   Rettig, W J ^a   Gorrell, M D ^a  

^a CENTENARY INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL PEPTIDASE; DIPEPTIDYL PEPTIDASE IV; FIBROBLAST ACTIVATION PROTEIN; GELATINASE; GLIAL FIBRILLARY ACIDIC PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL ISOLATION; CELL STRUCTURE; CELLULAR DISTRIBUTION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME ASSAY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STELLATE CELL; TISSUE REGENERATION;

EID: 0033034717     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510290631     Document Type: Article

References (64)

1. 1 Rettig WJ, Su SL, Fortunato SR, Scanlan MJ, Raj BK, Garin‐Chesa P, Healey JH, et al. Fibroblast activation protein: purification, epitope mapping and induction by growth factors. Int J Cancer 1994 ; 58: 385–392. MEDLINE
2. 2 Scanlan MJ, Raj BK, Calvo B, Garin‐Chesa P, Sanz‐Moncasi MP, Healey JH, Old LJ, et al. Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers. Proc Natl Acad Sci U S A 1994 ; 91: 5657–5661. MEDLINE
3. 3 Rettig WJ, Chesa PG, Beresford HR, Feickert HJ, Jennings MT, Cohen J, Oettgen HF, et al. Differential expression of cell surface antigens and glial fibrillary acidic protein in human astrocytoma subsets. Cancer Res 1986 ; 46: 6406–6412. MEDLINE
4. 4 Rettig WJ, Garin‐Chesa P, Beresford HR, Oettgen HF, Melamed MR, Old LJ. Cell‐surface glycoproteins of human sarcomas: differential expression in normal and malignant tissues and cultured cells. Proc Natl Acad Sci U S A 1988 ; 85: 3110–3114. MEDLINE
5. 5 Garin‐Chesa P, Old LJ, Rettig WJ. Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers. Proc Natl Acad Sci U S A 1990 ; 87: 7235–7239. MEDLINE
6. 6 Welt S, Divgi CR, Scott AM, Garin‐Chesa P, Finn RD, Graham M, Carswell EA, et al. Antibody targeting in metastatic colon cancer: a phase I study of monoclonal antibody F19 against a cell‐surface protein of reactive tumor stromal fibroblasts. J Clin Oncol 1994 ; 12: 1193–1203. MEDLINE
7. 7 Abbott C, Baker E, Sutherland GR, McCaughan GW. Genomic organisation, exact localization, and tissue expression of the human CD26 (dipeptidyl peptidase IV) gene. Immunogenetics 1994 ; 40: 331–338. MEDLINE
8. 8 Mathew S, Scanlan MJ, Mohan Raj BK, Murty VV, Garin‐Chesa P, Old LJ, Rettig WJ, et al. The gene for fibroblast activation protein alpha (FAP), a putative cell surface‐bound serine protease expressed in cancer stroma and wound healing, maps to chromosome band 2q23. Genomics 1995 ; 25: 335–337. MEDLINE
9. 9 Marguet D, Bernard A, David F, Lazaro‐Trueba I, Pierres M. Structural organization of the DP IV gene and its relationship with DPX and FAP‐alpha transcripts. In: Fleischer B, ed. Dipeptidyl peptidase IV(CD26) in metabolism and the immune response. Georgetown, TX: R.G. Landes Company, 1995 ; 37–53.
10. 10 McCaughan GW, Wickson JE, Creswick PF, Gorrell MD. Identification of the bile canalicular cell surface molecule GP110 as the ectopeptidase dipeptidyl peptidase IV: an analysis by tissue distribution, purification and N‐terminal amino acid sequence. Hepatology 1990 ; 11: 534–544. MEDLINE
11. 11 Gorrell MD, Wickson J, McCaughan GW. Expression of the rat CD26 antigen (dipeptidyl peptidase IV) on subpopulations of rat lymphocytes. Cell Immunol 1991 ; 134: 205–215. MEDLINE
12. 12 Fleischer B. CD26: a surface protease involved in T‐cell activation. Immunol Today 1994 ; 15: 180–184. MEDLINE
13. 13 Niedermeyer J, Scanlan MJ, Garin‐Chesa P, Daiber C, Fiebig HH, Old LJ, Rettig WJ, et al. Mouse fibroblast activation protein: Molecular cloning, alternative splicing and expression in the reactive stroma of epithelial cancers. Int J Cancer 1997 ; 71: 383–389. MEDLINE
14. 14 Vlasak R, Vilas U, Strobl B, Kreil G. cDNA cloning and expression of secreted Xenopus laevis dipeptidyl aminopeptidase IV. Eur J Biochem 1997 ; 247: 107–113. MEDLINE
15. 15 Matsumoto Y, Bishop GA, McCaughan GW. Altered zonal expression of the CD26 antigen (dipeptidyl peptidase IV) in human cirrhotic liver. Hepatology 1992 ; 15: 1048–1053. MEDLINE
16. 16 Friedman SL. Molecular mechanisms of hepatic fibrosis and principles of therapy. J Gastroenterol 1997 ; 32: 424–430. MEDLINE
17. 17 Alcolado R, Arthur MJP, Iredale JP. Pathogenesis of liver fibrosis. Clin Sci 1997 ; 92: 103–112. MEDLINE
18. 18 Iredale JP, Benyon RC, Arthur MJP, Ferris WF, Alcolado R, Winwood PJ, Clark N, et al. Tissue inhibitor of metalloproteinase‐1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis. Hepatology 1996 ; 24: 176–184. MEDLINE
19. 19 Mathew J, Geerts A, Burt AD. Pathobiology of hepatic stellate cells. Hepatogastroenterology 1996 ; 43: 72–91. MEDLINE
20. 20 Yamaoka K, Nouchi T, Marumo F, Sato C. Alpha‐smooth‐muscle actin expression in normal and fibrotic human livers. Dig Dis Sci 1993 ; 38: 1473–1479. MEDLINE
21. 21 Enzan H, Himeno H, Iwamura S, Saibara T, Onishi S, Yamamoto Y, Hara H. Immunohistochemical identification of Ito cells and their myofibroblastic transformation in adult human liver. Virchows Arch 1994 ; 424: 249–256. MEDLINE
22. 22 Niki T, De Bleser PJ, Xu G, Van Den Berg K, Wisse E, Geerts A. Comparison of glial fibrillary acidic protein and desmin staining in normal and CCl‐induced fibrotic rat livers. Hepatology 1996 ; 23: 1538–1545.
23. 23 Niki T, Pekny M, Hellemans K, De Bleser P, Van den Berg K, Vaeyens F, Quartier E, et al. Class VI intermediate filament protein nestin is induced during activation of rat hepatic stellate cells. Hepatology 1999 ; 29: 520–527. MEDLINE
24. 24 Knittel T, Aurisch S, Neubauer K, Eichhorst S, Ramadori G. Cell‐type‐specific expression of neural cell adhesion molecule (N‐CAM) in Ito cells of rat liver. Am J Pathol 1996 ; 149: 449–455. MEDLINE
25. 25 Ansorge S, Buhling F, Hoffman T, Kahne T, Neubert K, Reinhold D. DP IV/CD26 on human lymphocytes: functional roles in cell growth and cytokine regulation. In: Fleischer B, ed. Dipeptidyl Peptidase IV(CD26) in Metabolism and the Immune Response. Austin, TX: R.G. Landes Company. 1995 ; 163–184.
26. 26 Bishop GA, Rokahr KL, Napoli J, McCaughan GW. Intragraft cytokine mRNA levels in human liver allograft rejection analysed by reverse transcription and semiquantitative polymerase chain reaction amplification. Transplant Immunol 1993 ; 1: 253–261.
27. 27 Chen W‐T, Gendrault J, Steffan A, Jeandidier E, Kirn A. Characterization and main properities of cultured fat‐storing cells from human and mouse livers; their characterization with viruses. In: Wisse E, Knook D, Decker K, eds. Cells of The Hepatic Sinusoid. Volume II, ed II. Rijswijk, the Netherlands: Kupffer Cell Foundation, 1989 ; 429–433.
28. 28 Win KM, Charlotte F, Mallat A, Cherqui D, Martin N, Mavier P, Preaux A M, et al. Mitogenic effect of transforming growth factor‐beta 1 on human Ito cells in culture: evidence for mediation by endogenous platelet‐derived growth factor. Hepatology 1993 ; 18: 137–145. MEDLINE
29. 29 McCall MN, Shotton DM, Barclay AN. Expression of soluble isoforms of rat CD45. Analysis by electron microscopy and use in epitope mapping of anti‐CD45R monoclonal antibodies. Immunology 1992 ; 76: 310–317. MEDLINE
30. 30 Davis SJ, Ward HA, Puklavec MJ, Willis AC, Williams AF, Barclay AN. High level expression in Chinese hamster ovary cells of soluble forms of CD4 T lymphocyte glycoprotein including glycosylation variants. J Biol Chem 1990 ; 265: 10410–10418. MEDLINE
31. 31 Maniatis T, Fritsh E, Sambrook J. Molecular Cloning. A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Press. 1989 ; 561–563.
32. 32 Gorrell MD, Levy MT, Abbott CA, Washington EA, McCaughan GW. CD26: ADA binding, immunoblotting and species cross reactivity examined using recombinant proteins. In: Kishimoto T, ed. Leucocyte Typing VI. New York: Garland Publishing Inc.. 1997 ; 484–485.
33. 33 Coligan J, Kruisbeek A, Margulies D, Shevach E, Strober W. Current Protocols in Immunology. New York: John Wiley and Sons Inc., 1994: 812.
34. 34 Yao PM, Buhler JM, d'Ortho MP, Lebargy F, Delclaux C, Harf A, Lafuma C. Expression of matrix metalloproteinase gelatinases A and B by cultured epithelial cells from human bronchial explants. J Biol Chem 1996 ; 271: 15580–15589. MEDLINE
35. 35 Abbott CA, Gorrell MD, Kobayashi Y, Kawasaki T, Liddle C, Bishop GA, McCaughan GW. Increased serum levels of dipeptidyl peptidase IV (CD26) in rats undergoing liver regeneration. Int Hepatol Commun 1995 ; 4: 165–174.
36. 36 Duke‐Cohan JS, Morimoto C, Rocker JA, Schlossman SF. A novel form of Dipeptidylpeptidase IV found in human serum—isolation, characterization, and comparison with T lymphocyte membrane dipeptidylpeptidase IV (CD26). J Biol Chem 1995 ; 270: 14107–14114. MEDLINE
37. 37 Rettig WJ, Garin‐Chesa P, Healey JH, Su SL, Ozer HL, Schwab M, Albino AP, et al. Regulation and heteromeric structure of the fibroblast activation protein in normal and transformed cells of mesenchymal and neuroectodermal origin. Cancer Res 1993 ; 53: 3327–3335. MEDLINE
38. 38 Gard AL, White FP, Dutton GR. Extra‐neural glial fibrillary acidic protein (GFAP) immunoreactivity in perisinusoidal stellate cells of rat liver. J Neuroimmunol 1985 ; 8: 359–375. MEDLINE
39. 39 Neubauer K, Knittel T, Aurisch S, Fellmer P, Ramadori G. Glial fibrillary acidic protein—a cell type specific marker for Ito cells in vivo and in vitro. J Hepatol 1996 ; 24: 719–730. MEDLINE
40. 40 Abbott CA, Gorrell MD, Levy MT, McCaughan GW. Molecular analyses of human and rat dipeptidyl peptidase IV. Adv Exp Med Biol 1997 ; 421: 161–170. MEDLINE
41. 41 Kameoka J, Tanaka T, Nojima Y, Schlossman SF, Morimoto C. Direct association of adenosine deaminase with a T cell activation antigen, CD26. Science 1993 ; 261: 466–469. MEDLINE
42. 42 Morrison ME, Vijayasaradhi S, Engelstein D, Albino AP, Houghton AN. A marker for neoplastic progression of human melanocytes is a cell surface ectopeptidase. J Exp Med 1993 ; 177: 1135–1143. MEDLINE
43. 43 Pineiro‐Sanchez ML, Goldstein LA, Dodt J, Howard L, Yeh Y, Chen W‐T. Identification of the 170‐kDa melanoma membrane‐bound gelatinase (seprase) as a serine integral membrane protease. J Biol Chem 1997 ; 272: 7595–7601. MEDLINE
44. 44 Goldstein LA, Ghersig G, Pineiro‐Sanchez ML, Salamone M, Yeh Y, Flessate D, Chen W. Molecular cloning of seprase: a serine integral membrane protease from human melanoma. Biochim Biophys Acta 1997 ; 1361: 11–19. MEDLINE
45. 45 Romain PL, Schlossman SF. Human T lymphocyte subsets. Functional heterogeneity and surface recognition structures. J Clin Invest 1984 ; 74: 1559–1565. MEDLINE
46. 46 Dack C, Day CP, Johnson SJ, Burt AD. Population kinetics of GFAP‐positive cells following experimental acute liver injury. 8th International Symposium on Cells of the Hepatic Sinusoid. Bordeaux, France: Kupffer Cell Foundation, 1996 ; 32.
47. 47 Hautekeete ML, Geerts A. The hepatic stellate (Ito) cell: its role in human liver disease. Virchows Arch 1997 ; 430: 195–207. MEDLINE
48. 48 Schmitt‐Graff A, Kruger S, Bochard F, Gabbiani G, Denk H. Modulation of alpha smooth muscle actin and desmin expression in perisinusoidal cells of normal and diseased human livers. Am J Pathol 1991 ; 138: 1233–1242. MEDLINE
49. 49 Nouchi T, Tanaka Y, Tsukada T, Sato C, Marumo F. Appearance of alpha smooth muscle actin positive cells in hepatic fibrosis. Liver 1991 ; 11: 100–105. MEDLINE
50. 50 Niedermeyer J, Enenkel B, Park JE, Lenter M, Rettig WJ, Damm K, Schnapp A. Mouse fibroblast activation protein‐conserved Fap gene organization and biochemical function as a serine protease. Eur J Biochem 1998 ; 254: 650–654. MEDLINE
51. 51 Arthur MJ. Degradation of matrix proteins in liver fibrosis. Pathol Res Prac 1994 ; 190: 825–833.
52. 52 Arthur MJP. Role of Ito cells in the degradation of matrix in liver. J Gastroenterol Hepatol 1995 ; 10: 1–12. MEDLINE
53. 53 Gianelli G, Falk‐Marzillier J, Schiraldi O, Stetler‐Stevenson WG, Quaranta V. Induction of cell migration by matrix metalloprotease‐2 cleavage of laminin‐5. Science 1997 ; 277: 225–227. MEDLINE
54. 54 Iredale JP. Tissue inhibitors of metalloproteinases in liver fibrosis. Int J Biochem Cell Biol 1997 ; 29: 43–54. MEDLINE
55. 55 Goldberg GI, Wilhelm SM, Kronberger A, Bauer EA, Grant GA, Eisen AZ. Human fibroblast collagenase. Complete primary structure and homology to an oncogene transformation‐induced rat protein. J Biol Chem 1986 ; 261: 6600–6605. MEDLINE
56. 56 Nagase H, Jackson RC, Brinckerhoff CE, Vater CA, Harris ED. A precursor form of latent collagenase produced in a cell‐free system with mRNA from rabbit synovial cells. J Biol Chem 1981 ; 256: 11951–11954. MEDLINE
57. 57 Nagase H, Brinckerhoff CE, Vater CA, Harris ED. Biosynthesis and secretion of procollagenase by rabbit synovial fibroblasts. Inhibition of procollagenase secretion by monensin and evidence for glycosylation of procollagenase. Biochem J 1983 ; 214: 281–288. MEDLINE
58. 58 Dano K, Andreasen PA, Grondahl‐Hansen J, Kristensen P, Nielsen LS, Skriver L. Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res 1985 ; 44: 139–266. MEDLINE
59. 59 Leyland H, Gentry J, Arthur MJP, Benyon RC. The plasminogen‐activating system in hepatic stellate cells. Hepatology 1996 ; 24: 1172–1178. MEDLINE
60. 60 Drucker DJ, Shi Q, Crivici A, Sumner‐Smith M, Tavares W, Hill M, DeForest L, et al. Regulation of the biological activity of glucagon‐like peptide 2 in vivo by dipeptidyl peptidase IV. Nat Biotechnol 1997 ; 15: 673–677. MEDLINE
61. 61 Oravecz T, Pall M, Roderiquez G, Gorrell MD, Ditto M, Nguyen NY, Boykins R, et al. Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)‐mediated cleavage. J Exp Med 1997 ; 186: 1865–1872. MEDLINE
62. 62 Proost P, De Meester I, Schols D, Struyf S, Lambeir AM, Wuyts A, Opdenakker G, et al. Amino‐terminal truncation of chemokines by CD26/dipeptidyl‐peptidase IV. Conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV‐1‐infection. J Biol Chem 1998 ; 273: 7222–7227. MEDLINE
63. 63 Sato Y, Tsuboi R, Lyons R, Moses H, Rifkin DB. Characterization of the activation of latent TGF‐beta by co‐cultures of endothelial cells and pericytes or smooth muscle cells: a self‐regulating system. J Cell Biol 1990 ; 111: 757–763. MEDLINE
64. 64 Nakamura K, Komiya M. Proteolysis of human tumor necrosis factor (TNF) by endo‐ and exopeptidases: process of proteolysis and formation of active fragments. Biol Pharm Bull 1996 ; 19: 672–677. MEDLINE